Xtant Medical Holdings, Inc. - Laporan Laba Rugi (TTM)

Xtant Medical Holdings, Inc.
US ˙ NYSEAM ˙ US98420P3082

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Xtant Medical Holdings, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 56 53 51 56 55 55 56 56 57 58 63 68 78 91 101 111 114 117 122 128
Change (%) -5.24 -4.19 8.70 -0.43 -0.08 0.75 0.54 1.23 2.29 8.60 7.87 15.54 16.36 10.88 9.59 2.63 2.99 4.29 4.47
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 19 19 18 20 22 23 24 25 25 26 28 29 32 36 39 43 45 49 51 51
Change (%) -2.68 -3.77 8.12 9.22 5.77 4.16 6.08 -0.08 2.74 7.77 3.12 10.86 12.59 8.83 9.20 4.57 10.15 4.26 -0.46
% of Revenue 34.58 35.52 35.68 35.49 38.93 41.21 42.60 44.95 44.37 44.56 44.22 42.28 40.56 39.25 38.52 38.39 39.11 41.83 41.82 39.84
Gross Operating Profit 37 34 33 36 34 32 32 31 32 32 35 39 47 55 62 68 69 68 71 77
Change (%) -6.59 -4.43 9.02 -5.74 -3.81 -1.63 -3.57 2.30 1.94 9.26 11.64 18.97 18.94 12.20 9.84 1.42 -1.61 4.31 8.01
% of Revenue 65.42 64.48 64.32 64.51 61.07 58.79 57.40 55.05 55.63 55.44 55.78 57.72 59.44 60.75 61.48 61.61 60.89 58.17 58.18 60.16
SG&A 37 34 32 34 35 35 36 36 37 38 41 45 54 64 73 80 81 78 76 75
Change (%) -7.65 -6.23 5.06 1.95 0.69 3.72 0.75 1.63 2.55 7.27 10.40 19.26 19.86 12.92 9.95 1.45 -3.79 -1.94 -2.35
% of Revenue 66.35 64.66 63.28 61.16 62.62 63.11 64.96 65.09 65.35 65.51 64.71 66.23 68.36 70.41 71.71 71.94 71.11 66.43 62.47 58.39
R&D 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2
Change (%) -16.41 -4.72 21.73 11.15 2.72 -0.11 -0.35 -3.70 9.71 -4.26 -6.96 32.02 24.16 26.42 27.00 9.79 1.27 -3.52 -3.04
% of Revenue 1.40 1.23 1.23 1.37 1.53 1.57 1.56 1.55 1.47 1.58 1.39 1.20 1.37 1.46 1.67 1.93 2.07 2.03 1.88 1.75
OpEx 58 54 51 54 57 59 61 62 63 65 69 74 87 101 113 125 128 129 130 128
Change (%) -6.09 -5.35 6.35 4.71 2.64 3.83 2.81 0.87 2.72 7.31 7.27 16.16 17.24 11.65 9.94 2.66 1.16 0.39 -1.62
% of Revenue 102.33 101.41 100.18 98.02 103.08 105.89 109.12 111.59 111.19 111.65 110.33 109.71 110.29 111.13 111.91 112.26 112.29 110.30 106.17 99.98
Operating Income -1 -1 -0 1 -2 -3 -5 -6 -6 -7 -6 -7 -8 -10 -12 -14 -14 -12 -8 0
Change (%) -42.63 -87.62 -1,283.87 -254.68 91.07 56.12 27.72 -2.25 6.51 -3.77 1.40 22.53 25.78 18.65 12.90 2.87 -13.74 -37.54 -100.38
% of Revenue -2.33 -1.41 -0.18 1.98 -3.08 -5.89 -9.12 -11.59 -11.19 -11.65 -10.33 -9.71 -10.29 -11.13 -11.91 -12.26 -12.29 -10.30 -6.17 0.02
Interest Expense -7 -6 -5 -3 -1 -1 -1 -2 -2 -2 -2 -2 -3 -3 -3 -3 -4 -4 -4 -4
Change (%) -8.43 -18.52 -38.10 -58.63 -20.21 35.98 14.63 7.22 1.74 12.77 20.28 13.94 12.35 8.85 6.47 12.89 8.22 5.05 0.27
% of Revenue -11.59 -11.20 -9.53 -5.43 -2.25 -1.80 -2.43 -2.77 -2.93 -2.92 -3.03 -3.38 -3.33 -3.22 -3.16 -3.07 -3.38 -3.55 -3.57 -3.43
Net Income -8 -7 -5 -3 -3 -5 -7 -8 -9 -8 -8 -9 3 1 -2 -3 -18 -16 -12 -5
Change (%) -11.35 -35.08 -37.97 15.70 48.20 45.04 13.89 6.85 -0.86 -1.59 5.75 -131.19 -76.03 -351.82 100.54 427.66 -6.47 -27.10 -61.80
% of Revenue -14.07 -13.17 -8.92 -5.09 -5.92 -8.77 -12.63 -14.31 -15.10 -14.64 -13.26 -13.00 3.51 0.72 -1.64 -3.00 -15.45 -14.03 -9.80 -3.58

Source: Capital IQ

Other Listings
DE:XMS € 0.52
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista